Latigo Biotherapeutics, Inc. (LTGO)

Latigo Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Latigo Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-111.18	-109.17	-61.18
Depreciation & Amortization	0.23	0.25	0.24
Share-Based Compensation	-	6.73	2.77
Other Operating Activities	7.48	4.64	7.21
Operating Cash Flow	-103.47	-97.56	-50.96
Capital Expenditures	-0.03	-0.14	-0.07
Investing Cash Flow	-0.03	-0.14	-0.07
Share Issuance / Repurchase	-	149.5	0.61
Financing Cash Flow	49.83	149.5	0.61
Net Cash Flow	-53.67	51.8	-50.42
Free Cash Flow	-103.5	-97.69	-51.03